News Conference News EACTS 2025 Nearly Half of CABG Patients Have New-Onset AF, but It Often Doesn’t Last Yael L. Maxwell October 13, 2025
News Conference News HFSA 2025 CCM-D Delivers Safe, Effective Integrated Therapy in HFrEF Yael L. Maxwell September 29, 2025
News Conference News NOW PUBLISHED: Compared with PV Isolation Alone, AI-Guided Ablation Lowers AF at 12 Months Yael L. Maxwell February 18, 2025
News Conference News AHA 2024 Infections No More Likely With Reconditioned Versus New Pacemakers Yael L. Maxwell November 22, 2024
News Conference News Concomitant AF Procedures During Non-Mitral Surgery Less Likely in Women Yael L. Maxwell May 09, 2024
News Conference News AHA 2022 Botulinum Toxin Injections No Help for Postoperative AF: NOVA Yael L. Maxwell November 07, 2022
News Conference News ACC 2022 Large Smartwatch Study Confirms AF in Most Patients Who Seek Care: mAF-App II Yael L. Maxwell April 07, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Conference News AHA 2021 Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown Yael L. Maxwell November 14, 2021
News Conference News ESC 2021 In HFrEF, AI Shows Promise For Predicting Beta Blocker Response Yael L. Maxwell September 03, 2021
News Conference News ESC 2020 More Than Half of Patients See a GP in the 2 Weeks Before OHCA Yael L. Maxwell August 28, 2020
News Conference News ACC 2020 Sodium Nitrite Fails to Improve Survival in Out-of-Hospital Cardiac Arrest Yael L. Maxwell April 08, 2020
News Conference News SCAI 2019 Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib Yael L. Maxwell May 24, 2019
News Conference News ACC 2019 Apple Watch May Detect A-fib in the General Population, but at What Cost? Yael L. Maxwell March 16, 2019
News Conference News CRT 2019 New ALERTS Data Support Use of Implantable Cardiac Monitor in High-Risk ACS Patients—With Caveats Yael L. Maxwell March 03, 2019
News Conference News ACC 2017 My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time Shelley Wood March 23, 2017
News Conference News ACC 2017 RE-CIRCUIT: Doubts Over Dabigatran for A-fib Ablations Put to Rest Yael L. Maxwell March 20, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016